Details about the neuroanatomical projections from ORBl to PERI
To view more data and metadata associated with each report, click on its ID.
Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
---|---|---|---|---|---|---|---|
91832 | Orbital area lateral part | Perirhinal area | strong | biotinylated dextran amine (BDA) | a dense plexus of labeled axons and axonal varicosities in rostral PER, especially in the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 7B, 11D). Collator note: the terminal field is mostly in layer III, with some extension in layer V. See Fig. 7B, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
91836 | Orbital area lateral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | […] labeling extended farther rostrally in this case (Fig. 7A) compared with MO (Fig. 4) and ventral VO (Fig. 6) cases. Collator note: strong-moderate label in both PERI and ECT, rostralmost. Terminals are intermingled with fibers of passage, and are distributed in layers III and V. See Fig. 7A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
91837 | Orbital area lateral part | Perirhinal area | light | biotinylated dextran amine (BDA) | At more caudal levels, labeling in PER decreased in density (Fig. 7C) and was absent caudally in PER (Fig. 7D). Collator note: weak terminal field in layer III, at this level. See Fig. 7C, Swanson Atlas Levels 35-36. | Kondo H. & Witter M.P., 2014 | |
91839 | Orbital area lateral part | Perirhinal area | not present | biotinylated dextran amine (BDA) | At more caudal levels, labeling in PER decreased in density (Fig. 7C) and was absent caudally in PER (Fig. 7D). Collator note: Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 | |
91848 | Orbital area lateral part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | The injection produced labeled axons and terminals rostrally in PER, but labeling was weak (Figs. 8A,B, 11E) or absent in the middle and caudal portions of PER (Fig. 8C–E). Collator note: weak-moderate label at best in the rostral PERI. The label is mostly in layers II-III, with very few terminals in V. See Fig. 8A-B, Swanson Atlas Levels 30-32. | Kondo H. & Witter M.P., 2014 | |
91849 | Orbital area lateral part | Perirhinal area | not present | biotinylated dextran amine (BDA) | The injection produced labeled axons and terminals rostrally in PER, but labeling was weak (Figs. 8A,B, 11E) or absent in the middle and caudal portions of PER (Fig. 8C–E). Collator note: no label in the caudal two thirds of the PERI. See Fig. 8C-E, Swanson Atlas Levels 35-43. | Kondo H. & Witter M.P., 2014 | |
91863 | Orbital area lateral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: weak-moderate field in the deep layers of the PERI, and moderate-strong in the dorsal part, extending into the ECT in this level. See Fig. 11F. | Kondo H. & Witter M.P., 2014 |
General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Further details associated to record number 91849:
|
---|